UNII 1P9D0Z171K

BUTYLATED HYDROXYTOLUENE

Unique Ingredient Identifier 1P9D0Z171K is listed as a ingredient substance

• RN: 128-37-0
• EC: 204-881-4
• NCIT: C322
• RXCUI: 1848
• PUBCHEM: 31404
• MF: C15H24O
• INCHI KEY: NLZUEZXRPGMBCV-UHFFFAOYSA-N
• SMILES: CC1=CC(=C(O)C(=C1)C(C)(C)C)C(C)(C)C

Dosage Forms

UNII 1P9D0Z171K BUTYLATED HYDROXYTOLUENE is commonly included in medications in the following forms.

Route	Dosage Form	Potency
BUCCAL	GUM, CHEWING	0.21 MG
INTRAMUSCULAR	INJECTION	0.03 %
INTRAVENOUS	INJECTABLE	0.02 mg/mL
INTRAVENOUS	INJECTION	0.002 %
INTRAVENOUS	POWDER, FOR INJECTION SOLUTION, LYOPHILIZED	0.002 %
INTRAVENOUS	SOLUTION, INJECTION	0.002 %
INTRAVENOUS INFUSION	SOLUTION, INJECTION	0.01 mg/mL
IV(INFUSION)	INJECTION	0.006 %
IV(INFUSION)	POWDER, FOR INJECTION SOLUTION	NA
NASAL	SPRAY, METERED	0.01 %
ORAL	CAPSULE	0.38 MG
ORAL	CAPSULE, COATED, SOFT GELATIN	0.035 MG
ORAL	CAPSULE, SOFT GELATIN	0.25 MG
ORAL	FILM, SOLUBLE	0.06 MG
ORAL	SOLUTION	189 ug/1mL
ORAL	SOLUTION	0.19 MG/1ML
ORAL	SOLUTION, LIQUID, CONCENTRATE, ORAL	0.1 MG/1ML
ORAL	TABLET	0.42 MG
ORAL	TABLET (IMMED./COMP. RELEASE), FILM COATED	0.15 MG
ORAL	TABLET, COATED	NA
ORAL	TABLET, CONTROLLED RELEASE	0.21 MG
ORAL	TABLET, EXTENDED RELEASE	0.4 MG
ORAL	TABLET, FILM COATED	0.36 MG
ORAL	TABLET, FOR SUSPENSION	0.1 MG
ORAL	TABLET, ORALLY DISINTEGRATING	0.3 MG
ORAL	TABLET, SUSTAINED ACTION	0.17 MG
ORAL	TABLET, SUSTAINED ACTION, COATED	0.24 MG
RECTAL	SUPPOSITORY	0.21 MG
SUBLINGUAL	TABLET	0.13 mg
TOPICAL	AEROSOL	0.1 %W/W
TOPICAL	AEROSOL, FOAM	0.1 %
TOPICAL	CREAM	0.05 %W/W
TOPICAL	CREAM, AUGMENTED	0.2 %W/W
TOPICAL	CREAM, EMULSION, SUSTAINED RELEASE	0.1 %W/W
TOPICAL	EMULSION, AEROSOL FOAM	0.1 %W/W
TOPICAL	EMULSION, CREAM	0.1 %W/W
TOPICAL	GEL	0.1 %W/W
TOPICAL	LOTION	0.021 %W/W
TOPICAL	OINTMENT	NA
TOPICAL	SHAMPOO	0.1 %W/W
TOPICAL	SOLUTION	0.1 %W/W
TOPICAL	SPRAY	0.1 %W/W
TOPICAL	SUSPENSION	0.016 %W/W
TOPICAL	SWAB	NA
TRANSDERMAL	GEL	0.05 %
VAGINAL	EMULSION, CREAM	0.05 %
VAGINAL	SUPPOSITORY	NA